{
    "root": "7f88e44d-2f31-44c6-8d56-fdca3da40626",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Diazepam",
    "value": "20250314",
    "ingredients": [
        {
            "name": "DIAZEPAM",
            "code": "Q3JTX2Q7TU",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_49575"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        }
    ],
    "indications": {
        "text": "diazepam tablets indicated management anxiety disorders short-term relief symptoms anxiety . anxiety tension associated stress everyday life usually require treatment anxiolytic . acute alcohol withdrawal , diazepam tablets may useful symptomatic relief acute agitation , tremor , impending acute delirium tremens hallucinosis . diazepam tablets useful adjunct relief skeletal muscle spasm due reflex spasm local pathology ( inflammation muscles joints , secondary trauma ) , spasticity caused upper motor neuron disorders ( cerebral palsy paraplegia ) , athetosis , stiff-man syndrome . oral diazepam tablets may used adjunctively convulsive disorders , although proved useful sole therapy . effectiveness diazepam tablets long-term , , 4 months , assessed systematic . physician periodically reassess usefulness individual patient .",
        "doid_entities": [
            {
                "text": "anxiety (DOID:2030)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2030"
            },
            {
                "text": "delirium tremens (DOID:8639)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8639"
            },
            {
                "text": "cerebral palsy (DOID:1969)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1969"
            },
            {
                "text": "paraplegia (DOID:607)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_607"
            },
            {
                "text": "stiff-man syndrome (DOID:13366)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13366"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "stiff-man syndrome",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_353298"
            },
            {
                "disease": "acute delirium tremens",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_90062"
            }
        ]
    },
    "contraindications": {
        "text": "individualized maximum beneficial effect . usual daily dosages given meet needs patients , may require higher doses . cases increased cautiously avoid effects . adults : usual daily dose : management anxiety disorders relief symptoms anxiety . depending upon severity symptoms\u20142 mg 10 mg , 2 4 times daily symptomatic relief acute alcohol withdrawal . 10 mg , 3 4 times first 24 hours , reducing 5 mg , 3 4 times daily needed . adjunctively relief skeletal muscle spasm . 2 mg 10 mg , 3 4 times daily adjunctively convulsive disorders . 2 mg 10 mg , 2 4 times daily geriatric patients , presence debilitating disease . 2 mg 2.5 mg , 1 2 times daily initially ; increase gradually needed tolerated . pediatric patients : varied responses cns-acting drugs , initiate therapy lowest dose increase required . pediatric patients 6 months . 1 mg 2.5 mg , 3 4 times daily initially ; increase gradually needed tolerated .",
        "doid_entities": [
            {
                "text": "anxiety (DOID:2030)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2030"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "diazepam tablets , usp available containing 2 mg , 5 mg 10 mg diazepam , usp . 10 mg tablets green , round , scored tablets debossed mylan 477 one side scored side . available follows : ndc 68788-8462-2 bottles 20 tablets ndc 68788-8462-3 bottles 30 tablets storage : store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) . [ usp controlled room temperature . ] protect light . dispense tight , light-resistant container defined usp using child-resistant closure . pharmacist : dispense medication guide prescription .",
    "adverseReactions": "diazepam tablets contraindicated patients known hypersensitivity diazepam , lack sufficient experience , pediatric patients 6 months age . diazepam tablets also contraindicated patients myasthenia gravis , severe respiratory insufficiency , severe hepatic insufficiency , sleep apnea syndrome . may used patients open-angle glaucoma receiving appropriate therapy , contraindicated acute narrow-angle glaucoma .",
    "indications_original": "Diazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. \n                  In acute alcohol withdrawal, diazepam tablets may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis. \n                  Diazepam tablets are a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia), athetosis, and stiff-man syndrome. \n                  Oral diazepam tablets may be used adjunctively in convulsive disorders, although it has not proved useful as the sole therapy. \n                  The effectiveness of diazepam tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.",
    "contraindications_original": "Dosage should be individualized for maximum beneficial effect. While the usual daily dosages given below will meet the needs of most patients, there will be some who may require higher doses. In such cases dosage should be increased cautiously to avoid adverse effects. \n                  \n                     \n                     \n                     \n                        \n                           \n                              \n                                 ADULTS:\n                              \n                           \n                           \n                              \n                                 USUAL DAILY DOSE:\n                              \n                           \n                        \n                        \n                           \n                              \n                                 Management of Anxiety Disorders and Relief of Symptoms of Anxiety.\n                              \n                           \n                           \n                              Depending upon severity of symptoms\u20142 mg to 10 mg, 2 to 4 times daily\n                           \n                        \n                        \n                           \n                              \n                                 Symptomatic Relief in Acute Alcohol Withdrawal.\n                              \n                           \n                           \n                              10 mg, 3 or 4 times during the first 24 hours, reducing to 5 mg, 3 or 4 times daily as needed.\n                           \n                        \n                        \n                           \n                              \n                                 Adjunctively for Relief of Skeletal Muscle Spasm.\n                              \n                           \n                           \n                              2 mg to 10 mg, 3 or 4 times daily\n                           \n                        \n                        \n                           \n                              \n                                 Adjunctively in Convulsive Disorders.\n                              \n                           \n                           \n                              2 mg to 10 mg, 2 to 4 times daily\n                           \n                        \n                        \n                           \n                              \n                                 Geriatric Patients, or in the presence of debilitating disease.\n                              \n                           \n                           \n                              2 mg to 2.5 mg, 1 or 2 times daily initially; increase gradually as needed and tolerated.\n                           \n                        \n                        \n                           \n                              \n                                 PEDIATRIC PATIENTS:\n                              \n                           \n                           \n                        \n                        \n                           \n                              Because of varied responses to CNS-acting drugs, initiate therapy with lowest dose and increase as required. Not for use in pediatric patients under 6 months.\n                           \n                           \n                              1 mg to 2.5 mg, 3 or 4 times daily initially; increase gradually as needed and tolerated.",
    "warningsAndPrecautions_original": "Diazepam Tablets, USP are available containing 2 mg, 5 mg or 10 mg of diazepam, USP.\n                  The 10 mg tablets are green, round, scored tablets debossed with MYLAN over 477 on one side and scored on the other side. They are available as follows:\n                  \n                     \n                        \u00a0NDC 68788-8462-2\tBottles of 20 tablets\n                     \n                        \u00a0NDC 68788-8462-3\tBottles of 30 tablets\n                  \n                  \n                     Storage: Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F). [See USP Controlled Room Temperature.]\n                  \n                  \n                     Protect from light.\n                  \n                  Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.\n                  \n                     PHARMACIST:\u00a0Dispense a Medication Guide with each prescription.",
    "adverseReactions_original": "Diazepam tablets are contraindicated in patients with a known hypersensitivity to diazepam and, because of lack of sufficient clinical experience, in pediatric patients under 6 months of age. Diazepam tablets are also contraindicated in patients with myasthenia gravis, severe respiratory insufficiency, severe hepatic insufficiency, and sleep apnea syndrome. They may be used in patients with open-angle glaucoma who are receiving appropriate therapy, but is contraindicated in acute narrow-angle glaucoma.",
    "drug": [
        {
            "name": "Diazepam",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_49575"
        }
    ]
}